LOMBARD MEDICAL, INC. Inactive Instrument
Lombard Medical, Inc. Stock Other OTC
Equities
EVARF
KYG555981094
Advanced Medical Equipment & Technology
| Sales 2015 | 15.11M 18.83M | Sales 2016 | 12.17M 15.16M | Capitalization | 16.77M 20.89M |
|---|---|---|---|---|---|
| Net income 2015 | -37M -46.1M | Net income 2016 | -31M -38.62M | EV / Sales 2015 | 1.17 x |
| Net cash position 2015 | 9.22M 11.48M | Net Debt 2016 | 13.76M 17.15M | EV / Sales 2016 | 2.51 x |
| P/E ratio 2015 |
-0.63
x | P/E ratio 2016 |
-0.39
x | Employees | - |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Lombard Medical, Inc. is a medical device company. The Company is focused solely on the minimally invasive treatment of aortic disease. The Company partners with MicroPort Endovastec to offer Minos abdominal aortic aneurysm (AAA) stent-graft, the Hercules TAA stent graft and the Castor Branched Thoracic stent graft, in addition to its own Aorfix and Altura stent grafts. The Companyâs products include Minos, Aorfix, Altura, Meridian, Hercules, Castor, and Hercules Balloon.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
